TWI475962B - Method for preparing soybean peptide-calcium chelate - Google Patents

Method for preparing soybean peptide-calcium chelate Download PDF

Info

Publication number
TWI475962B
TWI475962B TW100136710A TW100136710A TWI475962B TW I475962 B TWI475962 B TW I475962B TW 100136710 A TW100136710 A TW 100136710A TW 100136710 A TW100136710 A TW 100136710A TW I475962 B TWI475962 B TW I475962B
Authority
TW
Taiwan
Prior art keywords
calcium
soybean
peptide
preparing
hydrolyzate
Prior art date
Application number
TW100136710A
Other languages
Chinese (zh)
Other versions
TW201315390A (en
Inventor
Chien Ti Chang
Ming Yu Hung
yu hui Liu
Shiao Cheng Chuang
Hsiang Ling Lai
Fu Ning Chien
Su Er Liou
Yi Hong Chen
Chu Chin Chen
Original Assignee
Food Industry Res & Dev Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Food Industry Res & Dev Inst filed Critical Food Industry Res & Dev Inst
Priority to TW100136710A priority Critical patent/TWI475962B/en
Priority to CN201110387656.XA priority patent/CN103040000B/en
Publication of TW201315390A publication Critical patent/TW201315390A/en
Application granted granted Critical
Publication of TWI475962B publication Critical patent/TWI475962B/en

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

大豆胜肽-鈣螯合物之製備方法Method for preparing soybean peptide-calcium chelate

本發明係有關於大豆胜肽之製備方法,且特別有關於大豆胜肽-鈣螯合物之製備方法。The present invention relates to a method for preparing a soybean peptide, and particularly relates to a method for preparing a soybean peptide-calcium chelate.

大豆的食用有悠久的歷史,大豆的營養價值高,富含蛋白質、纖維,而且存在許多機能性成份維護身體健康,包括植物固醇可以降低膽固醇,異黃酮舒緩婦女更年期症狀,維生素E和皂素提供抗氧化功能。對於素食者更是獲取營養很好的食物選擇。近年來西方社會也大力提倡大豆產品,大豆的健康形象與日俱增。Soy has a long history of consumption. Soybeans have high nutritional value, are rich in protein and fiber, and have many functional ingredients to maintain good health. Phytosterols can lower cholesterol, and isoflavones relieve women's menopausal symptoms, vitamin E and saponin. Provides antioxidant function. For vegetarians, it is a good food choice for getting nutrition. In recent years, Western society has also vigorously promoted soy products, and the health image of soybeans is increasing day by day.

在華人日常生活中豆漿是非常普遍的食品,但是與牛奶相較,豆漿鈣含量明顯偏低,根據美國農業部資料一般牛奶的鈣含量為113毫克/100公克,豆漿鈣含量僅39毫克/100公克(USDA,2008)。如果在傳統市場或早餐店面的家庭式自製豆漿可能攙水疑慮增加,鈣含量會更低,所獲得鈣更有限。所以對於經常食用豆漿產品的族群攝取鈣量需求特別注意。Soymilk is a very common food in Chinese daily life, but compared with milk, the calcium content of soy milk is obviously low. According to the US Department of Agriculture, the calcium content of milk is 113 mg/100 g, and the calcium content of soy milk is only 39 mg/100. Gram (USDA, 2008). If the home-made homemade soymilk in the traditional market or breakfast store may have increased doubts about water, the calcium content will be lower and the calcium obtained will be more limited. Therefore, special attention should be paid to the demand for calcium intake by the population that regularly consume soy milk products.

鈣在人體生理、生化機能扮演許多重要角色,包括組成骨骼主要元素、血液凝結、肌肉收縮、酸鹼平衡、維護細胞膜的通透性、血壓調控、參與許多酵素反應等,是一不可缺少的營養素。人體生長發育持續著吸取鈣質,儲存”骨本”,一直到35至45歲達到最高峰,然後隨著年齡增長骨鈣漸漸流失,女性更年期後流失速度更快(Bronner. et al.,1999)。因此,人終其一生必須時時注意鈣質的攝取,因為鈣質必須從日常膳食中獲取,無法自行製造。根據我國國民營養調查顯示,台灣地區男性平均攝取量為520 mg,女性平均為542 mg,若以美國RDA(1,200 mg)或RDI(1,300 mg)的標準來衡量,是嚴重攝取不足。基於國人鈣質普遍缺乏,衛生署在2002年修訂的「國人膳食營養素參考攝取量」,就大幅修正鈣質的攝取量,從原本的成人每天600毫克,提高到800~1000毫克(http://www.doh.gov.tw)。而且近年來老年骨折頻率增高,與鈣質的攝取量不足,導致骨骼疏鬆有相當大的關聯。據衛生署調查發現,台灣地區六十五歲以上的人口,每九人即有一人罹患骨質疏鬆症,其中女性更高達每四人就有一人(http://www.doh.gov.tw)。所以改善骨骼健康,首要任務即是攝取足夠的鈣質。Calcium plays many important roles in human physiological and biochemical functions, including the formation of major bone elements, blood coagulation, muscle contraction, acid-base balance, maintenance of cell membrane permeability, blood pressure regulation, participation in many enzyme reactions, etc., is an indispensable nutrient. . The growth and development of the human body continues to absorb calcium and store the "bone bones" until the peak reaches 35 to 45 years old. Then, as the age increases, the bone calcium gradually loses and the female loses faster after menopause (Bronner. et al., 1999). ). Therefore, people must pay attention to calcium intake from time to time, because calcium must be obtained from daily diet and cannot be manufactured by itself. According to the National Nutrition Survey of China, the average intake of males in Taiwan is 520 mg, and the average female is 542 mg. If measured by American RDA (1,200 mg) or RDI (1,300 mg), it is severely under-acquired. Based on the general lack of calcium in the Chinese population, the Department of Health's revised “National Dietary Nutrient Reference Intake” revised in 2002 significantly revised the intake of calcium from 600 mg per day for adults to 800 to 1000 mg (http:/ /www.doh.gov.tw). Moreover, in recent years, the frequency of fractures in the elderly has increased, and the intake of calcium is insufficient, leading to a considerable correlation between bone loosening. According to a survey conducted by the Department of Health, one in nine people in Taiwan is suffering from osteoporosis, and one in every four people (http://www.doh.gov.tw) . Therefore, the primary task of improving bone health is to get enough calcium.

一般較熟悉的鈣來源是由乳製品提供,但許多人有乳醣不耐症,此外,在台灣地區,乳製品的人均消費量較西方國家少很多,此也是降低鈣攝取總量的原因。The more common sources of calcium are provided by dairy products, but many people have lactose intolerance. In addition, in Taiwan, the per capita consumption of dairy products is much lower than in Western countries, which is also the reason for reducing the total calcium intake.

研究發現,乳製品中的酪蛋白(casein)在經過胃及腸的蛋白分解酵素分解後會產生抑制鈣離子在鹼性環境下沉澱之胜肽成分,稱之為酪蛋白磷酸肽(Caseinophosphopeptide,CPP)。鈣離子在小腸的吸收,除了在少部份(15-20%重量百分比)在前端的十二指腸部份係需要維生素D的主動運輸,大多數鈣離子進入人體循環系統,靠的是空腸和迴腸段的被動運輸(60-65%重量百分比)(Bronner,F. 1998. Calcium Absorption-A Paradigm for Mineral Absorption J. Nutr. 128: 917-920;Bronner,F. and Pansu,D. 1999. Nutritional Aspects of Calcium Absorption. J. Nutr. 129: 9-12).由於小腸後段的pH值為弱鹼性,因此在含有SerP-SerP-SerP-Glu-Glu序列的CPP胜肽片段存在時,就可維持鈣離子的溶解狀態並進行穿透腸細胞間隙的被動運輸(Ferraretto,A.. Signorile,A Gravaghi,C. Fiorilli,A. and Tettamanti,G. 2001. Casein Phosphopeptides Influence Calcium Uptake by Cultured Human Intestinal HT-29 Tumor Cells J. Nutr. 131: 1655-1661)。為了避免缺乏鈣導致骨質疏鬆等疾病的發生,除了增加鈣的攝取外,增加鈣的吸收率也是一好方法,然而,乳醣不耐症患者不適合利用乳製品中的酪蛋白來促進鈣吸收。Studies have found that casein in dairy products, after decomposition by proteolytic enzymes in the stomach and intestines, produces a peptide component that inhibits the precipitation of calcium ions in an alkaline environment, called Caseinophosphopeptide (CPP). ). Calcium ion absorption in the small intestine, except for a small part (15-20% by weight) in the duodenum part of the front end requires the active transport of vitamin D, most of the calcium ions enter the human circulatory system, relying on the jejunum and ileum Passive transport (60-65% by weight) (Bronner, F. 1998. Calcium Absorption-A Paradigm for Mineral Absorption J. Nutr. 128: 917-920; Bronner, F. and Pansu, D. 1999. Nutritional Aspects of Calcium Absorption. J. Nutr. 129: 9-12). Since the pH of the posterior segment of the small intestine is weakly alkaline, calcium can be maintained in the presence of a CPP peptide fragment containing the SerP-SerP-SerP-Glu-Glu sequence. The dissolved state of ions and passive transport through the intestinal cell space (Ferraretto, A.. Signorile, A Gravaghi, C. Fiorilli, A. and Tettamanti, G. 2001. Casein Phosphopeptides Influence Calcium Uptake by Cultured Human Intestinal HT-29 Tumor Cells J. Nutr. 131: 1655-1661). In order to avoid the occurrence of diseases such as osteoporosis caused by the lack of calcium, in addition to increasing calcium intake, it is also a good method to increase the absorption rate of calcium. However, patients with lactose intolerance are not suitable for using casein in dairy products to promote calcium absorption.

因此將豆漿產品補充鈣源,成為產品開發的重要商機。在技術層面上,強化鈣豆漿在製造時,添加鈣存在加工障礙,因為豆漿中大豆蛋白會因添加的鈣離子引起疏水性聚集現象,進而使大豆蛋白沉澱。解決此種加工問題,添加螯合劑與鈣離子形成穩定結構,降低大豆蛋白沉澱是常用的方法。例如六偏磷酸鈉、檸檬酸鈉、磷酸氫鈉等皆是常用豆漿化學添加物,提高產品穩定性(Pathomrungsiyounggul,et al.,2010)。在健康意識提高下,食品加工領域中添加物的使用需格外留意,不必要的化學物添加物應避免,取而代之的天然配料或添加物則是較安心的考量。Therefore, adding soy milk products to calcium sources has become an important business opportunity for product development. On the technical level, in the production of calcium soymilk, the addition of calcium has processing obstacles, because the soy protein in the soy milk causes hydrophobic aggregation due to the added calcium ions, thereby precipitating the soy protein. To solve such processing problems, it is a common method to add a chelating agent to form a stable structure with calcium ions and to reduce soy protein precipitation. For example, sodium hexametaphosphate, sodium citrate, sodium hydrogen phosphate, etc. are commonly used soy chemical additives to improve product stability (Pathomrungsiyounggul, et al., 2010). With increased health awareness, the use of additives in the food processing sector requires special attention. Unnecessary chemical additives should be avoided, and natural ingredients or additives replaced by them are more reassuring considerations.

過去已有學者提出以化學合成的方式產生單一種促鈣吸收胜肽,然其成本相當高,較難實際運用(Galzigna,L.,Domergue,N.,Previero,A. 1998. A synthetic calcium-chelating L-glutamyl-L-serine phosphate(Glu-Ser.P)enhances calcium absorption in the rat. J Pept Res. 52(1):15-18)。另外尚有學者提出以化學添加物做為螯合劑或穩定劑達成豆漿強化鈣之目的(Pathomrungsiyounggul,P.,Lewis,M.J. and Grandison,A. S. 2010. Effects of calcium-chelating agents and pasteurization on certain properties of calcium-fortified soy milk. Food Chem. 118:808-814;Luhadiya,A.P.C.,Yang,D.K.,Heisey,M. T. 2006.Calcium fortified beverages.US Patent 6994877 B2),然化學添加物仍有安全上的考量,不比天然螯合劑,且其中Luhadiya et al.之產品最後的酸鹼值為鹼性8.25,較難實際飲用。此外亦有學者提出以化學添加物檸檬酸鈉做為螯合劑來製作加鈣豆漿(目野和荒木,2005)。大陸專利CN 101161114 B中揭露利用商業蛋白分解酵素水解大豆蛋白產生大豆胜肽來製造大豆胜肽-鈣混合物,但其成本較高。In the past, some scholars have proposed to produce a single calcium-promoting peptide by chemical synthesis, but the cost is quite high and it is difficult to use it practically (Galzigna, L., Domergue, N., Previero, A. 1998. A synthetic calcium- Chelating L-glutamyl-L-serine phosphate (Glu-Ser. P) enhances calcium absorption in the rat. J Pept Res. 52(1): 15-18). In addition, some scholars have proposed to use chemical additives as a chelating agent or stabilizer to achieve the purpose of soymilk to strengthen calcium (Pathomrungsiyounggul, P., Lewis, MJ and Grandison, AS 2010. Effects of calcium-chelating agents and pasteurization on certain properties of calcium -fortified soy milk. Food Chem. 118:808-814; Luhadiya, APC, Yang, DK, Heisey, MT 2006. Calcium fortified beverages. US Patent 6994877 B2), although chemical additives still have safety considerations, no more than natural A chelating agent, and the final pH value of the product of Luhadiya et al. is 8.25, which is more difficult to drink. In addition, some scholars have proposed the use of the chemical additive sodium citrate as a chelating agent to make calcium soy milk (Mino and Araki, 2005). The mainland patent CN 101161114 B discloses the use of commercial proteolytic enzymes to hydrolyze soy protein to produce a soybean peptide to produce a soybean peptide-calcium mixture, but at a higher cost.

綜上所述,人們亟需一種低製造成本,並可以讓乳醣不耐症患者食用之增加鈣的吸收率,符合實用性且無安全疑慮的豆漿飲品。In summary, there is a need for a low manufacturing cost, and can increase the absorption rate of calcium for patients with lactose intolerance, in line with practical and safe safety concerns.

本發明提供一種大豆胜肽-鈣螯合物之製備方法,其步驟包括:將一含有大豆蛋白之原料與水混合,以形成一含水量約45%-65%重量百分比的混合物;將一麴菌菌群接種於上述混合物得到一培養物,其中上述麴菌菌群包括:Aspergillus oryzae、Aspergillus sojae、或上述之混合,且上述麴菌菌群的接種量佔上述大豆蛋白原料重量的約0.006%-0.05%;將上述培養物進行固態發酵得到一發酵產物,其中上述固態發酵的條件包括:相對溼度約85%-95%和發酵溫度介於約攝氏23~35度;將上述發酵產物進行水解反應得到一大豆水解液;將上述大豆水解液依序進行澄清化處理及固液分離後得到一大豆澄清水解液;以及於上述大豆澄清水解液直接加入鈣離子混合,其中大豆胜肽和鈣離子之莫耳數比為2:1~0.5:1,並調整含水量至60~65%重量百分比,及pH值介於6.5~7,獲得一含有大豆胜肽-鈣螯合物之液體。The invention provides a method for preparing a soybean peptide-calcium chelate, the method comprising the steps of: mixing a raw material containing soy protein with water to form a mixture having a water content of about 45%-65% by weight; The inoculum is inoculated into the above mixture to obtain a culture, wherein the above-mentioned bacterium group includes: Aspergillus oryzae, Aspergillus sojae, or a mixture thereof, and the inoculum of the above-mentioned sputum group accounts for about 0.006% by weight of the above-mentioned soybean protein material. -0.05%; solid-fermenting the above culture to obtain a fermentation product, wherein the conditions of the solid-state fermentation include: a relative humidity of about 85%-95% and a fermentation temperature of about 23-35 degrees Celsius; hydrolyzing the fermentation product. The reaction obtains a soybean hydrolyzate; the soybean hydrolyzate is sequentially subjected to clarification treatment and solid-liquid separation to obtain a soybean clarified hydrolyzate; and the soybean clarification hydrolyzate is directly added with calcium ion mixture, wherein the soybean peptide and calcium ion are mixed. The molar ratio is 2:1~0.5:1, and the water content is adjusted to 60~65% by weight, and the pH is between 6.5 and 7, to obtain a soybean peptide-calcium chelate Liquid of the compound.

本發明另提供一種大豆胜肽-鈣螯合物之製備方法,其步驟包括:將一含有大豆蛋白之原料與水混合,以形成一含水量約45%-65%重量百分比的混合物;將一麴菌菌群接種於上述混合物得到一培養物,其中上述麴菌菌群包括:Aspergillus oryzae、Aspergillus sojae、或上述之混合,且上述麴菌菌群的接種量佔上述大豆蛋白原料重量的約0.006%-0.05%;將上述培養物進行固態發酵得到一發酵產物,其中上述固態發酵的條件包括:相對溼度約85%-95%和發酵溫度介於約攝氏23~35度;將上述發酵產物進行水解反應得到一大豆水解液;將上述大豆水解液依序進行澄清化處理及固液分離後得到一大豆澄清水解液;將上述大豆澄清水解液與大豆油和卵磷脂均勻混合,其中大豆油之濃度為大豆水解液固形物的2~8%重量百分比,卵磷脂之濃度為大豆油的0.01~0.05%重量百分比,得到一混合物;將上述混合物進行乾燥得到一大豆胜肽粉末;將該大豆胜肽粉末和鈣離子溶於水中,其中該大豆胜肽粉末中之大豆胜肽和鈣離子的莫耳數比例為2:1~0.5:1,並調整含水量至60~65%重量百分比,及pH值介於6.5~7,獲得一含有大豆胜肽-鈣螯合物之液體。The invention further provides a method for preparing a soybean peptide-calcium chelate, the method comprising: mixing a raw material containing soy protein with water to form a mixture having a water content of about 45%-65% by weight; The inoculum is inoculated to the above mixture to obtain a culture, wherein the above-mentioned bacterium group includes: Aspergillus oryzae, Aspergillus sojae, or a mixture thereof, and the inoculum of the above-mentioned sputum group accounts for about 0.006 by weight of the above-mentioned soybean protein material. %-0.05%; solid-fermenting the above culture to obtain a fermentation product, wherein the conditions of the solid-state fermentation include: relative humidity of about 85%-95% and fermentation temperature of about 23-35 degrees Celsius; Hydrolyzing to obtain a soybean hydrolyzate; the soybean hydrolyzate is sequentially clarified and solid-liquid separated to obtain a soybean clarified hydrolyzate; the soybean clarified hydrolyzate is uniformly mixed with soybean oil and lecithin, wherein the soybean oil is uniformly mixed The concentration is 2 to 8% by weight of the solids of the soybean hydrolysate, and the concentration of the lecithin is 0.01 to 0.05% by weight of the soybean oil to obtain a mixture; The mixture is dried to obtain a soybean peptide powder; the soybean peptide powder and calcium ions are dissolved in water, wherein the ratio of the molar ratio of the soybean peptide to the calcium ion in the soybean peptide powder is 2:1 to 0.5: 1, and adjust the water content to 60-65% by weight, and the pH value is between 6.5 and 7, to obtain a liquid containing the soybean peptide-calcium chelate.

本發明尚提供一種鈣強化豆漿之製備方法,其係將前述之大豆胜肽-鈣螯合物添加於豆漿中。The present invention further provides a method for preparing calcium-fortified soybean milk, which comprises adding the aforementioned soybean peptide-calcium chelate compound to soybean milk.

本發明還提供一種鈣強化豆漿,由前述之鈣強化豆漿之製備方法製造而得,其中上述鈣強化豆漿之鈣含量大於40mg/100ml。The invention also provides a calcium-fortified soybean milk obtained by the method for preparing the calcium-enhanced soybean milk, wherein the calcium-enhanced soybean milk has a calcium content of more than 40 mg/100 ml.

為了讓本發明之上述和其他目的、特徵、和優點能更明顯易懂,下文特舉較佳實施例,作詳細說明如下:The above and other objects, features and advantages of the present invention will become more apparent and understood.

本發明提供一種大豆胜肽-鈣螯合物的製備方法。在一實施例中,係將大豆粉以麴菌進行固態發酵分解後,再進行水解反應,然後進行澄清步驟,得到澄清之水解液,之後於上述大豆澄清水解液直接加入氯化鈣混合,並調整含水量及pH值,獲得一含有大豆胜肽-鈣螯合物之液體。在另一實施例中,可將上述大豆澄清水解液進行一製粉步驟,再將上述大豆胜肽粉和鈣離子加水混合攪拌溶解,調整酸鹼值,製成一含有大豆胜肽-鈣螯合物的胜肽產物。The invention provides a preparation method of soybean peptide-calcium chelate. In one embodiment, the soybean powder is subjected to solid state fermentation decomposition by sputum, and then subjected to a hydrolysis reaction, followed by a clarification step to obtain a clarified hydrolyzate, and then directly added calcium chloride to the soybean clarified hydrolyzate, and The water content and pH are adjusted to obtain a liquid containing the soybean peptide-calcium chelate. In another embodiment, the soybean clarification hydrolyzate may be subjected to a milling step, and the soybean peptide powder and the calcium ion may be mixed with water and stirred to dissolve, and the pH value is adjusted to prepare a soybean-containing peptide-calcium chelate. The peptide product of the substance.

本發明是利用大豆來製造大豆胜肽,其原理是利用Aspergillus oryzae、Aspergillus sojae、或上述菌種之混合的麴菌菌群來處理含有大豆蛋白的原料,以進行固態發酵,其中上述大豆蛋白的來源包括但不限於大豆粉、脫脂大豆粉、脫脂大豆片、大豆分離蛋白、大豆粕、豆餅、或上述之組合。在一實施例中,上述麴菌接種量佔原料總重量的約0.006%-0.05%,較佳約0.008%~0.02%,更佳約0.013%。在上述固態發酵中,可使用各種緩衝液,例如:檸檬酸-檸檬酸鈉、乙酸-乙酸鈉、K2 HPO4 -KH2 PO4 、Na2 HPO4 -NaH2 PO4 、硼酸-氫氧化鈉、三羥甲基甲胺基丙磺酸、N,N-雙(2-羥乙基)甘氨酸、三羥甲基氨基甲烷、N-三-(羥甲基)甲基氨基乙酸、4-(2-羥乙基)-1-哌嗪乙烷磺酸半鈉鹽、N-三(羥甲基)甲基-2-氨基乙磺酸、3-(N-嗎非啉)乙磺酸哌嗪-N,N'-二(2-乙磺酸)、二甲基胂酸檸檬酸鈉、2-嗎啉乙磺酸等,調節固態發酵所需的水分,其所需的水分佔原料與水混合物總重的約45%-65%,較佳約50%~60%,更佳約55%。在一實施例中,上述固態發酵可在pH值約5~7;相對溼度約85%-95%;發酵溫度介於約攝氏23~35度;發酵的時間約2~5天的條件下進行。The present invention utilizes soybean to produce a soybean peptide, the principle of which is to use a mixture of Aspergillus oryzae, Aspergillus sojae, or a mixture of the above species to treat a soybean protein-containing raw material for solid-state fermentation, wherein the soybean protein is Sources include, but are not limited to, soy flour, defatted soy flour, defatted soy flakes, soy protein isolate, soy meal, bean cake, or combinations thereof. In one embodiment, the inoculum inoculation amount is from about 0.006% to 0.05%, preferably from about 0.008% to 0.02%, more preferably about 0.013%, based on the total weight of the raw materials. In the above solid state fermentation, various buffers can be used, for example: citric acid-sodium citrate, acetic acid-sodium acetate, K 2 HPO 4 -KH 2 PO 4 , Na 2 HPO 4 -NaH 2 PO 4 , boric acid-hydrogen peroxide Sodium, trishydroxymethylmethylaminopropanesulfonic acid, N,N-bis(2-hydroxyethyl)glycine, trishydroxymethylaminomethane, N-tris-(hydroxymethyl)methylaminoacetic acid, 4- (2-hydroxyethyl)-1-piperazineethanesulfonic acid hemi-sodium salt, N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid, 3-(N-morpholine)ethanesulfonic acid Piperazine-N,N'-bis(2-ethanesulfonic acid), sodium citrate citrate, 2-morpholineethanesulfonic acid, etc., regulate the water required for solid-state fermentation, and the required water accounts for the raw materials. The total weight of the mixture with water is from about 45% to about 65%, preferably from about 50% to about 60%, more preferably about 55%. In one embodiment, the solid state fermentation may be performed at a pH of about 5 to 7; a relative humidity of about 85% to 95%; a fermentation temperature of about 23 to 35 degrees Celsius; and a fermentation time of about 2 to 5 days. .

接著將上述發酵產物進行水解反應,以得到大豆水解液。在一實施例中,上述水解反應的進行步驟包括:將上述發酵產物與水以重量比約1:1~1:3的比例混合,較佳約1:2;水解的時間為約3-24小時,較佳約6小時;水解溫度介於約攝氏30-65度,較佳約攝氏45度。之後,再提高反應溫度至約攝氏90-95度以抑制酵素活性。The above fermentation product is then subjected to a hydrolysis reaction to obtain a soybean hydrolyzate. In one embodiment, the step of performing the hydrolysis reaction comprises: mixing the fermentation product with water at a weight ratio of about 1:1 to 1:3, preferably about 1:2; and the hydrolysis time is about 3-24. The hour is preferably about 6 hours; the hydrolysis temperature is between about 30 and 65 degrees Celsius, preferably about 45 degrees Celsius. Thereafter, the reaction temperature is raised to about 90-95 degrees Celsius to inhibit the activity of the enzyme.

之後再將上述大豆水解液進行固液分離等澄清化處理。例如,可先使用壓榨機,以油壓方式使之固液分離。然後液體加熱90℃、10分鐘後產生的沉澱,再以高速離心機去除沉澱,最後使用板框式壓濾機或是使用微過濾膜過濾水解液,並收集含有上述含有促進鈣吸收的胜肽之水解液。Thereafter, the soybean hydrolyzate is subjected to clarification treatment such as solid-liquid separation. For example, a press can be used to separate the solid and liquid by hydraulic pressure. The liquid is then heated at 90 ° C for 10 minutes to precipitate, and then the precipitate is removed by a high-speed centrifuge. Finally, the hydrolyzate is filtered using a plate and frame filter press or a microfiltration membrane, and the peptide containing the above-mentioned calcium-absorbing absorption is collected. Hydrolyzate.

接著將所得之水解液與鈣離子進行螯合,亦可將所得之水解液經過一製粉步驟再與鈣離子進行螯合製備成各種形式之大豆胜肽-鈣螯合物的胜肽產物。應可瞭解的是,本領域技術人員亦可使用任何其他適當的固液分離方式,以及其他適當的過濾手段。Then, the obtained hydrolyzate is chelated with calcium ions, and the obtained hydrolyzate may be subjected to a milling step and then chelated with calcium ions to prepare a peptide product of various forms of soybean peptide-calcium chelate. It will be appreciated that those skilled in the art can also use any other suitable solid-liquid separation means, as well as other suitable filtration means.

在一實施例中,上述水解液與鈣離子進行螯合的步驟,可包括:於上述大豆澄清水解液直接加入鈣離子混合,上述鈣離子的來源可擇自下列所組成之群組,例如但不限於:無機鈣,例如氯化鈣、碳酸鈣、磷酸鈣,以及有機鈣,例如乳酸鈣、檸檬酸鈣、葡萄糖酸鈣、以及上述之組合,其中大豆胜肽和鈣離子之混合的莫耳數比為2:1~0.5:1,較佳1:1,並調整含水量至60~65%,較佳65%,及pH值介於6.5~7,較佳6.7,獲得一含有大豆胜肽-鈣螯合物之液體。In one embodiment, the step of chelating the hydrolyzate with calcium ions may include: directly adding calcium ions to the soybean clarified hydrolysate, and the source of the calcium ions may be selected from the group consisting of, for example, It is not limited to: inorganic calcium, such as calcium chloride, calcium carbonate, calcium phosphate, and organic calcium, such as calcium lactate, calcium citrate, calcium gluconate, and combinations thereof, wherein a mixture of a soybean peptide and a calcium ion is used. The ratio is 2:1~0.5:1, preferably 1:1, and the water content is adjusted to 60~65%, preferably 65%, and the pH is between 6.5 and 7, preferably 6.7, to obtain a soybean containing win. A liquid of a peptide-calcium chelate.

在另一實施例中,上述水解液與鈣離子進行螯合的步驟,可包括:將上述澄清大豆水解液使用真空減壓濃縮機處理以取得高濃度大豆水解液(固形物40-60%重量百分比),添加大豆油為2-8%,最佳約5%重量百分比(以大豆水解液固形物為100%重量百分比)和卵磷脂為0.01%-0.05%,最佳約0.02%重量百分比(以大豆油重為100%重量百分比),使用超高速均質機充分混合,接著以噴霧乾燥機進行乾燥,條件為入口溫度145-160℃,較佳150-155℃,出口溫度85-110℃,較佳90-105℃,轉速35-40Hz,較佳40Hz,得到一大豆胜肽粉,接著將上述大豆胜肽粉和鈣離子加水於溫度25-50℃,較佳室溫下混合攪拌溶解,上述鈣離子的來源可擇自下列所組成之群組,例如但不限於:無機鈣,例如氯化鈣、碳酸鈣、磷酸鈣,以及有機鈣,例如乳酸鈣、檸檬酸鈣、葡萄糖酸鈣、以及上述之組合,其中胜肽螯合鈣的大豆胜肽和鈣離子的莫耳數比例為2:1~0.5:1,較佳為1:1,並調整含水量至60~65%,較佳65%,及調整酸鹼值pH 6.5~7,較佳為pH 6.7製成大豆胜肽-鈣螯合物的胜肽產物。In another embodiment, the step of chelating the hydrolyzate with calcium ions may include: treating the clarified soybean hydrolyzate with a vacuum decompression concentrator to obtain a high concentration soybean hydrolyzate (solid content 40-60% by weight) Percentage), adding soybean oil to 2-8%, preferably about 5% by weight (100% by weight of soy hydrolysate solids) and lecithin from 0.01% to 0.05%, optimally about 0.02% by weight ( Soybean oil weighs 100% by weight), thoroughly mixed using an ultra-high speed homogenizer, followed by drying with a spray dryer under the conditions of an inlet temperature of 145-160 ° C, preferably 150-155 ° C, and an outlet temperature of 85-110 ° C. Preferably, the temperature is 35-105 ° C, the rotation speed is 35-40 Hz, preferably 40 Hz, to obtain a soybean peptide powder, and then the soybean peptide powder and the calcium ion are added to the water at a temperature of 25-50 ° C, preferably at room temperature, and stirred and dissolved. The source of the above calcium ions may be selected from the group consisting of, but not limited to, inorganic calcium such as calcium chloride, calcium carbonate, calcium phosphate, and organic calcium such as calcium lactate, calcium citrate, calcium gluconate, And a combination of the above, wherein the peptide chelate The ratio of the molar ratio of the soybean peptide to the calcium ion is 2:1 to 0.5:1, preferably 1:1, and the water content is adjusted to 60-65%, preferably 65%, and the pH value is adjusted to 6.5. ~7, preferably pH 6.7, is the peptide product of the soybean peptide-calcium chelate.

在一實施例中,本發明鈣強化豆漿之製備可包括:取不同量之由上述製程所大豆胜肽-鈣螯合物添加至市售豆漿混合攪拌。採用本發明之製備方法所得之鈣強化豆漿的鈣含量可大於約40mg/100ml,較佳介於約40~90mg/100ml。在一鈣含量40mg/100ml的市售豆漿的實施例中,當添加鈣含量達60mg/100ml豆漿時,豆漿容易變稠,大豆蛋白因鈣離子產生凝聚現象,濃度愈高凝聚現象愈顯著,且易有蛋白沉澱分層產生。較佳可使添加鈣含量50mg/100ml豆漿以下,其外觀、口感皆佳,且此時所得之鈣強化豆漿產品最高鈣含量約可達90mg/100ml,接近牛奶的鈣含量(約113 mg/100ml)。In one embodiment, the preparation of the calcium fortified soymilk of the present invention may comprise: adding different amounts of the soy peptide-calcium chelate compound from the above process to the commercial soymilk for mixing. The calcium-fortified soymilk obtained by the preparation method of the present invention may have a calcium content of more than about 40 mg/100 ml, preferably about 40 to 90 mg/100 ml. In the embodiment of the commercially available soybean milk having a calcium content of 40 mg/100 ml, when the calcium content is 60 mg/100 ml of soybean milk, the soy milk is easily thickened, and the soy protein is agglomerated by calcium ions, and the higher the concentration, the more remarkable the aggregation phenomenon is, and It is easy to form a layer of protein precipitate. Preferably, the calcium content is 50 mg/100 ml or less, and the appearance and taste are good, and the calcium content of the calcium-fortified soymilk product obtained at this time is about 90 mg/100 ml, which is close to the calcium content of the milk (about 113 mg/100 ml). ).

本發明所提供之鈣強化豆漿之製備方法採用的大豆蛋白原料取得容易且成本低廉,並可以讓乳醣不耐症患者食用之增加鈣的吸收率,乃符合實用性且無安全疑慮的豆漿飲品,可提供消費者高於一般豆漿,甚至接近於牛奶所含之鈣含量。The soybean protein raw material used in the preparation method of the calcium-enhanced soybean milk provided by the invention is easy to obtain and low in cost, and can increase the absorption rate of calcium by the patient suffering from lactose intolerance, and is a soy milk drink which is practical and has no safety concerns. It can provide consumers with higher than normal soy milk, even close to the calcium content of milk.

【實施例】[Examples] 實施例1. 促進鈣吸收大豆胜肽之製造Example 1. Production of calcium absorption soy peptides

以脫脂大豆粉為原料,接種Aspergillus sojae,其中麴菌接種量為大豆原料總重量的0.013%,以重量百分濃度0.25%的CH3 COONa/0.25% HNaSO3 、pH=5.8之緩衝液調節水分至55%,在25~30℃、相對濕度95%以上之環境培養2天。Using defatted soybean meal as raw material, inoculate Aspergillus sojae, wherein the inoculum inoculum is 0.013% of the total weight of the soybean raw material, and the water is adjusted by a buffer of 0.25% by weight of CH 3 COONa/0.25% HNaSO 3 and pH=5.8. Up to 55%, cultured in an environment of 25 to 30 ° C and a relative humidity of 95% or more for 2 days.

接著進行水解反應,將大豆麴加水混合,其中大豆麴與水的比例為1:2,水解時間為6小時,水解溫度45℃,再提高溫度至90-95℃,維持10分鐘,以抑制酵素活性。Then, the hydrolysis reaction is carried out, and the soybean meal is mixed with water, wherein the ratio of soybean meal to water is 1:2, the hydrolysis time is 6 hours, the hydrolysis temperature is 45 ° C, and the temperature is further increased to 90-95 ° C for 10 minutes to inhibit the enzyme. active.

接著進行水解液的澄清化處理,先使用壓榨機,將大豆水解物置於濾袋中,平鋪於壓榨槽,以油壓方式使之固液分離。然後液體加熱90℃、10分鐘後產生的沉澱,再以遠心高速離心機(轉速16000rpm,台中,泉泰公司製造)去除沉澱,最後使用板框式壓濾機過濾(Seitz Orion,德國製造)或是使用微過濾膜(0.3μm)過濾水解液,得到澄清之大豆水解液。Next, the clarification treatment of the hydrolyzate is carried out, and the soybean hydrolyzate is first placed in a filter bag using a press, and laid flat in a press tank to separate the solid and liquid by oil pressure. The liquid was then heated to a temperature of 90 ° C for 10 minutes, and the precipitate was removed by a telecentric high-speed centrifuge (16,000 rpm, Taichung, manufactured by Quantai Co., Ltd.), and finally filtered using a plate and frame filter press (Seitz Orion, made in Germany) or The hydrolyzate was filtered using a microfiltration membrane (0.3 μm) to obtain a clarified soybean hydrolyzate.

實施例2. 大豆水解液抑制碳酸鈣沉澱之效果Example 2. Effect of Soy Hydrolysate on Inhibition of Calcium Carbonate Precipitation

根據Jin等人(J. Agnc. Food Chem. 2000)碳酸鈣結晶實驗略加修改,將1 ml樣品與1 ml濃度40 mM的氯化鈣和1.2 ml蒸餾水混合,然後加入0.8 ml濃度40 mM碳酸氫鈉後反應1小時,並使用0.1N氫氧化鈉滴定維持pH=8.5。將結束反應的混合液進行離心(離心力為2000 g),取上清液使用測鈣試劑組(台灣默克公司產物)測量鈣濃度,此為可溶鈣含量。According to Jin et al. (J. Agnc. Food Chem. 2000) calcium carbonate crystallization experiment slightly modified, 1 ml sample was mixed with 1 ml concentration of 40 mM calcium chloride and 1.2 ml of distilled water, then added 0.8 ml concentration of 40 mM carbonic acid The reaction was carried out for 1 hour with sodium hydrogen and maintained at pH = 8.5 by titration with 0.1 N sodium hydroxide. The mixed solution at the end of the reaction was centrifuged (centrifugal force: 2000 g), and the supernatant was taken to measure the calcium concentration using the calcium measuring reagent group (product of Taiwan Merck), which is the soluble calcium content.

抑制碳酸鈣結晶實驗中,由實施例1所得之大豆蛋白水解液對於碳酸鈣結晶有抑制效果,此效果的評估是在鹼性條件(pH=8.5)下,完全抑制碳酸鈣結晶的最低樣品濃度,如果發生碳酸鈣沉澱,上清液的鈣含量則降低;反之,上清液的鈣含量則不變。第1圖係為大豆蛋白水解液與酪蛋白磷酸肽比較其抑制碳酸鈣結晶之效果,其結果顯示有助鈣吸收的酪蛋白磷酸肽蛋白(CPP)最低抑制濃度為1.76x10-4 %,而本發明之大豆蛋白水解液的蛋白最低抑制濃度為2.16 x10-3 %。In the experiment for inhibiting calcium carbonate crystallization, the soy protein hydrolyzate obtained in Example 1 has an inhibitory effect on calcium carbonate crystals, and the effect is evaluated as the minimum sample concentration for completely inhibiting calcium carbonate crystals under alkaline conditions (pH=8.5). If calcium carbonate precipitates, the calcium content of the supernatant decreases; otherwise, the calcium content of the supernatant does not change. Fig. 1 is a graph showing the effect of inhibiting calcium carbonate crystallization in soybean protein hydrolysate compared with casein phosphopeptide, and the results showed that the minimum inhibitory concentration of casein phosphopeptide protein (CPP) which promotes calcium absorption was 1.76 x 10 -4 %. The protein of the soy protein hydrolyzate of the present invention has a minimum inhibitory concentration of 2.16 x 10 -3 %.

實施例3. 大豆水解液抑制之效果Example 3. Effect of inhibition of soybean hydrolysate

在本實施例中,選擇不同蛋白來源物質做比較,將1 ml樣品與1 ml濃度40 mM的氯化鈣和1.2 ml蒸餾水混合,然後加入0.8 ml濃度40 mM碳酸氫鈉後反應1小時,並使用0.1N氫氧化鈉滴定維持pH=8.5。將結束反應的混合液進行離心(離心力為2000 g),取上清液使用測鈣試劑組(台灣默克公司產物)測量鈣濃度,並在鹼性條件(pH=8.5)下,完全抑制碳酸鈣結晶的最低樣品濃度作為可溶鈣含量的評估標準。In this example, different protein source materials were selected for comparison, and 1 ml sample was mixed with 1 ml of 40 mM calcium chloride and 1.2 ml of distilled water, and then reacted for 1 hour by adding 0.8 ml of 40 mM sodium hydrogencarbonate. The pH was maintained at 8.5 using 0.1 N sodium hydroxide titration. The reaction mixture was centrifuged (centrifugal force: 2000 g), and the supernatant was used to measure the calcium concentration using the calcium measuring reagent group (product of Taiwan Merck), and under the alkaline condition (pH=8.5), the carbonic acid was completely inhibited. The lowest sample concentration of calcium crystallization is used as an evaluation criterion for soluble calcium content.

第2圖係為不同蛋白源物質其抑制碳酸鈣結晶之效果。其中游離氨基酸如麩氨酸鈉鹽(monosodium glutamate,MSG)、甘氨酸(glycine)抑制效果較差;接著是蛋白質如大豆分離蛋白(isolated soy protein,ISP)、酪蛋白(casein),雞精(essence of chicken,市售產物,為雞肉蛋白抽取物),其抑制碳酸鈣沉澱之效果優於前兩類;而本發明之大豆蛋白水解液(soy hydrolysate)最佳。可見單一的游離氨基酸或者是完整蛋白質與鈣離子螯合的情形不如蛋白質水解物,蛋白質經過程度不同的水解後,它們具有較好的抑制鈣沉澱效果。因此以胜肽型式的蛋白食材例如雞精,還有本發明利用麴菌酵素分解大豆蛋白水解液皆是不錯的抑鈣沉澱輔劑。Figure 2 is the effect of different protein source materials on the inhibition of calcium carbonate crystallization. Among them, free amino acids such as monosodium glutamate (MSG) and glycine have poor inhibitory effects; followed by proteins such as isolated soy protein (ISP), casein, and chicken of essence (essence of chicken). The commercially available product, which is a chicken protein extract), is superior to the first two types in inhibiting the precipitation of calcium carbonate; and the soy hydrolysate of the present invention is the best. It can be seen that a single free amino acid or a complete protein is not chelated with calcium ions as in the case of protein hydrolysates. After hydrolysis of proteins to different extents, they have a better effect of inhibiting calcium precipitation. Therefore, the protein material of the peptide type, such as chicken essence, and the method for decomposing soy protein hydrolyzate by using the bacteriocin enzyme are all good calcium precipitation precipitants.

實施例4. 促鈣吸收胜肽對動物鈣吸收的效果Example 4. Effect of calcium-promoting peptide on calcium absorption in animals

實驗方式類似賴愛姬的論文(臺灣營養學會雜誌,第21卷2期,1996),但略做修改,採用成年雌性鼠(Bltw:SD;購自樂斯科生物科技股份有限公司)飼養於各自獨立的代謝籠中,室溫維持在23±2℃,光照12小時,禁食一天待體內食物排除後,分別提供添加大豆分離蛋白為對照組或促鈣吸收胜肽做為實驗組,每組樣本數各為10隻,令動物任意攝食,每日收取糞便,6天後取走飼料,秤其所吃的總量,再等待一天排除吃的飼料後,收集及分析其排出糞便中的鈣含量。鈣的分析法為以硝酸做硝化反應後,以原子吸光儀測定。The experimental method is similar to that of Lai Ai Ji (The Journal of the Taiwan Nutrition Society, Vol. 21, No. 2, 1996), but with minor modifications, adult female rats (Bltw: SD; purchased from Lesco Biotech Co., Ltd.) are kept in separate countries. In the metabolic cage, the room temperature was maintained at 23±2°C, and the light was irradiated for 12 hours. After the food was removed for one day, the soybean protein isolate was added as the control group or the calcium-promoting peptide was used as the experimental group. The number is 10, the animals are fed ad libitum, the feces are collected daily, the feed is taken after 6 days, the total amount of food is taken, and after waiting for one day to exclude the feed, the calcium content in the excreted feces is collected and analyzed. . Calcium analysis is carried out by nitric acid and then measured by atomic absorption spectrometer.

鈣的總攝取量以吃的飼料量乘飼料中鈣的含量推估。鈣的吸收率為(總攝取量-糞便中的鈣含量)/總攝取量。The total intake of calcium is estimated by the amount of feed eaten by the amount of calcium in the feed. The absorption rate of calcium (total intake - calcium content in feces) / total intake.

第3圖顯示餵食促鈣吸收胜肽與大豆蛋白飼料老鼠的鈣吸收率。比較大豆蛋白或促鈣吸收胜肽的吸收率發現,促鈣吸收胜肽的吸收率顯著的較大豆蛋白高,平均值±95%信任區間,兩者間具有顯著差異(p<0.05)。Figure 3 shows the calcium absorption rate of mice fed with calcium-promoting peptide and soy protein. Comparing the absorption rate of soy protein or calcium-promoting peptide, it was found that the absorption rate of calcium-enhancing peptide was significantly higher than that of the larger soybean protein, and the mean value was ±95% confidence interval, and there was a significant difference between the two (p<0.05).

表1、大豆分離蛋白(對照組)及促鈣吸收胜肽(實驗組)之飼料配方(每2000克飼料中,各成分的量,單位為克)。Table 1. Soy protein isolate (control group) and calcium-enhancing peptide (experimental group) feed formulation (quantity of each component per gram of feed, in grams).

實施例5. 大豆胜肽粉末之製備方法Example 5. Preparation method of soybean peptide powder

將實施例1中所得之澄清大豆水解液使用真空減壓濃縮機處理取得高濃度大豆水解液(固形物40%),添加大豆油為大豆水解液固形物總重量的5%和卵磷脂為大豆油總重量的0.02%,使用超高速均質機充分混合,接著以噴霧乾燥機進行乾燥,條件為入口溫度150℃,出口溫度90℃,轉速40Hz,製成大豆胜肽粉末。The clear soybean hydrolyzate obtained in Example 1 was treated with a vacuum decompression concentrator to obtain a high concentration soybean hydrolyzate (solid content 40%), soybean oil was added as 5% of the total weight of the soybean hydrolysate solid, and lecithin was large. 0.02% of the total weight of soybean oil was thoroughly mixed using an ultra-high-speed homogenizer, followed by drying with a spray dryer under the conditions of an inlet temperature of 150 ° C, an outlet temperature of 90 ° C, and a rotational speed of 40 Hz to prepare a soybean peptide powder.

實施例6. 鈣強化豆漿之製備Example 6. Preparation of calcium fortified soy milk

將實施例5所得之大豆胜肽粉39.42公克和9公克氯化鈣加水90公克於室溫下混合攪拌溶解,大豆胜肽粉、氯化鈣、水形成的胜肽螯合鈣的比例為4.38:1:10(重量比),調整酸鹼值pH6.7,然後取不同量之螯合鈣溶液添加至市售豆漿(無糖豆漿,義美公司生產製造,台灣)混合攪拌。最後產品的感官品評和鈣含量如表所示(表1),測量鈣濃度使用測鈣試劑組(台灣默克公司產品)。在添加鈣含量60mg/100ml豆漿時,明顯感覺豆漿變稠,大豆蛋白因鈣離子產生凝聚現象,濃度愈高凝聚現象愈顯著,且有蛋白沉澱分層產生。最佳的產品品質是在添加鈣含量50mg/100ml以下,它們的外觀、口感皆佳,鈣強化豆漿產品最高鈣含量接近牛奶(90mg/100ml;牛奶鈣含量大約113 mg/100ml)。The soybean peptide powder obtained in Example 5 was 39.42 g and 9 g of calcium chloride and 90 g of water were mixed and stirred at room temperature, and the ratio of the peptide chelated calcium formed by the soybean peptide powder, calcium chloride and water was 4.38. : 1:10 (weight ratio), adjust the pH value of pH 6.7, and then add different amounts of chelated calcium solution to the commercially available soybean milk (sugar-free soy milk, manufactured by Yimei Co., Ltd., Taiwan) and mix and stir. The sensory evaluation and calcium content of the final product are shown in the table (Table 1), and the calcium concentration was measured using the calcium measuring reagent group (product of Taiwan Merck). When the calcium content of 60mg/100ml soy milk is added, it is obvious that the soy milk becomes thick, and the soy protein is agglomerated by calcium ions. The higher the concentration, the more remarkable the agglomeration phenomenon, and the protein precipitates are layered. The best product quality is the addition of calcium content below 50mg/100ml, their appearance and taste are good, the highest calcium content of calcium-fortified soymilk products is close to milk (90mg/100ml; milk calcium content is about 113 mg/100ml).

表1、不同鈣添加量至豆漿之感官品評Table 1. Sensory evaluation of different calcium additions to soymilk

義美公司無糖豆漿原始鈣含量40mg/100ml雖然本發明已以較佳實施例揭露如上,然其並非用以限定本發明,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可作些許之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 A number of changes and modifications may be made, and the scope of the invention is defined by the scope of the appended claims.

第1圖係為大豆蛋白水解液與酪蛋白磷酸肽比較其抑制碳酸鈣結晶之效果。Fig. 1 is a graph showing the effect of inhibiting the crystallization of calcium carbonate in comparison with the casein phosphopeptide by the soy protein hydrolyzate.

第2圖係為不同蛋白源物質其抑制碳酸鈣結晶之效果。Figure 2 is the effect of different protein source materials on the inhibition of calcium carbonate crystallization.

第3圖顯示餵食促鈣吸收胜肽與大豆蛋白飼料老鼠的鈣吸收率,平均值±95%信任區間,兩者間具有顯著差異(p<0.05)。Figure 3 shows the calcium absorption rate of the rats fed the calcium-promoting peptide and the soy protein feed, with a mean ±95% confidence interval, with significant differences between the two (p < 0.05).

Claims (12)

一種大豆胜肽-鈣螯合物之製備方法,其步驟包括:將一含有大豆蛋白之原料與水混合,以形成一含水量約45%-65%重量百分比的混合物;將一麴菌菌群接種於該混合物得到一培養物,其中該麴菌菌群包括:Aspergillus oryzaeAspergillus sojae 、或上述之混合,且該麴菌菌群的接種量佔該大豆蛋白原料重量的約0.006%-0.05%;將該培養物進行固態發酵得到一發酵產物,其中該固態發酵的條件包括:相對溼度約85%-95%和發酵溫度介於約攝氏23~35度;將該發酵產物進行水解反應得到一大豆水解液;將該大豆水解液依序進行澄清化處理及固液分離後得到一大豆澄清水解液;以及於該大豆澄清水解液直接加入鈣離子混合,其中大豆胜肽和鈣離子之莫耳數比為2:1~0.5:1,並調整含水量至60~65%重量百分比,及pH值介於6.5~7,獲得一含有大豆胜肽-鈣螯合物之液體。A method for preparing a soybean peptide-calcium chelate, the method comprising: mixing a raw material containing soy protein with water to form a mixture having a water content of about 45% to 65% by weight; Inoculation with the mixture to obtain a culture, wherein the bacillus flora comprises: Aspergillus oryzae , Aspergillus sojae , or a mixture thereof, and the inoculation amount of the sputum bacteria is about 0.006%-0.05% by weight of the soybean protein material. The culture is subjected to solid state fermentation to obtain a fermentation product, wherein the conditions of the solid state fermentation include: a relative humidity of about 85%-95% and a fermentation temperature of about 23 to 35 degrees Celsius; and the fermentation product is hydrolyzed to obtain a a soybean hydrolyzate; the soybean hydrolyzate is sequentially subjected to clarification treatment and solid-liquid separation to obtain a soybean clarified hydrolyzate; and the soybean clarification hydrolyzate is directly added with calcium ion mixture, wherein the soybean peptide and the calcium ion are in a molar state. The ratio is 2:1 to 0.5:1, and the water content is adjusted to 60-65% by weight, and the pH is between 6.5 and 7, to obtain a liquid containing the soybean peptide-calcium chelate. 一種大豆胜肽-鈣螯合物之製備方法,其步驟包括:將一含有大豆蛋白之原料與水混合,以形成一含水量約45%-65%重量百分比的混合物;將一麴菌菌群接種於該混合物得到一培養物,其中該 麴菌菌群包括:Aspergillus oryzaeAspergillus sojae 、或上述之混合,且該麴菌菌群的接種量佔該大豆蛋白原料重量的約0.006%-0.05%;將該培養物進行固態發酵得到一發酵產物,其中該固態發酵的條件包括:相對溼度約85%-95%和發酵溫度介於約攝氏23~35度;將該發酵產物進行水解反應得到一大豆水解液;將該大豆水解液依序進行澄清化處理及固液分離後得到一大豆澄清水解液;將該大豆澄清水解液與大豆油和卵磷脂均勻混合,其中大豆油之濃度為大豆水解液固形物的2~8%重量百分比,卵磷脂之濃度為大豆油的0.01~0.05%重量百分比,得到一混合物;將該混合物進行乾燥得到一大豆胜肽粉末;將該大豆胜肽粉末和鈣離子溶於水中,其中該大豆胜肽粉末中之大豆胜肽和鈣離子的莫耳數比例為2:1~0.5:1,並調整含水量至60~65%重量百分比,及pH值介於6.5~7,獲得一含有大豆胜肽-鈣螯合物之液體。A method for preparing a soybean peptide-calcium chelate, the method comprising: mixing a raw material containing soy protein with water to form a mixture having a water content of about 45% to 65% by weight; Inoculation with the mixture to obtain a culture, wherein the bacillus flora comprises: Aspergillus oryzae , Aspergillus sojae , or a mixture thereof, and the inoculation amount of the sputum bacteria is about 0.006%-0.05% by weight of the soybean protein material. The culture is subjected to solid state fermentation to obtain a fermentation product, wherein the conditions of the solid state fermentation include: a relative humidity of about 85%-95% and a fermentation temperature of about 23 to 35 degrees Celsius; and the fermentation product is hydrolyzed to obtain a Soybean hydrolyzate; the soybean hydrolyzate is sequentially clarified and solid-liquid separated to obtain a soybean clarified hydrolyzate; the soybean clarified hydrolysate is uniformly mixed with soybean oil and lecithin, wherein the concentration of soybean oil is soybean hydrolysis 2 to 8% by weight of the liquid solids, and the concentration of lecithin is 0.01 to 0.05% by weight of the soybean oil to obtain a mixture; the mixture is dried to obtain a soybean a peptide powder; the soybean peptide powder and calcium ions are dissolved in water, wherein the ratio of the molar ratio of the soybean peptide to the calcium ion in the soybean peptide powder is 2:1 to 0.5:1, and the water content is adjusted to 60 to 65% by weight, and a pH of 6.5 to 7, to obtain a liquid containing a soybean peptide-calcium chelate. 如申請專利範圍第1或2項所述之大豆胜肽-鈣螯合物之製備方法,其中該鈣離子的來源係擇自有機鈣、無機鈣、及上述之組合,其中該無機鈣係擇自下列所組成之群組:氯化鈣、碳酸鈣、磷酸鈣、以及上述之組合,該有機鈣係擇自下列所組成之群組:乳酸鈣、檸檬酸鈣、葡萄糖酸鈣、以及上述之組合。 The method for preparing a soybean peptide-calcium chelate compound according to claim 1 or 2, wherein the source of the calcium ion is selected from the group consisting of organic calcium, inorganic calcium, and a combination thereof, wherein the inorganic calcium is selected A group consisting of calcium chloride, calcium carbonate, calcium phosphate, and combinations thereof, selected from the group consisting of calcium lactate, calcium citrate, calcium gluconate, and the like. combination. 如申請專利範圍第1或2項所述之大豆胜肽-鈣螯合物之製備方法,其中該含有大豆蛋白之原料包括大豆粉、脫脂大豆粉、脫脂大豆片、大豆分離蛋白、大豆粕、豆餅、或上述之組合。 The method for preparing a soybean peptide-calcium chelate compound according to claim 1 or 2, wherein the soybean protein-containing material comprises soybean powder, defatted soybean powder, defatted soybean flakes, soy protein isolate, soybean meal, Bean cake, or a combination of the above. 如申請專利範圍第1或2項所述之大豆胜肽-鈣螯合物之製備方法,其中該固態發酵係在pH值約5~7下進行。 The method for preparing a soybean peptide-calcium chelate compound according to claim 1 or 2, wherein the solid state fermentation is carried out at a pH of about 5 to 7. 如申請專利範圍第1或2項所述之大豆胜肽-鈣螯合物之製備方法,其中該固態發酵的時間約2~5天。 The method for preparing a soybean peptide-calcium chelate compound according to claim 1 or 2, wherein the solid fermentation time is about 2 to 5 days. 如申請專利範圍第1或2項所述之大豆胜肽-鈣螯合物之製備方法,其中在該水解反應中,該發酵產物與水混合重量比為約1:1~1:3。 The method for preparing a soybean peptide-calcium chelate compound according to claim 1 or 2, wherein in the hydrolysis reaction, the weight ratio of the fermentation product to water is about 1:1 to 1:3. 如申請專利範圍第1或2項所述之大豆胜肽-鈣螯合物之製備方法,其中該水解反應的水解時間為約3-24小時。 The method for producing a soybean peptide-calcium chelate compound according to claim 1 or 2, wherein the hydrolysis reaction has a hydrolysis time of about 3 to 24 hours. 如申請專利範圍第1或2項所述之大豆胜肽-鈣螯合物之製備方法,其中該水解反應的水解溫度介於約攝氏30-65度。 The method for producing a soybean peptide-calcium chelate compound according to claim 1 or 2, wherein the hydrolysis reaction has a hydrolysis temperature of about 30 to 65 degrees Celsius. 如申請專利範圍第1或2項所述之大豆胜肽-鈣螯合物之製備方法,其中在該水解反應完成後,更包括提高反應溫度至約攝氏90-95度以抑制酵素活性。 The method for preparing a soybean peptide-calcium chelate compound according to claim 1 or 2, wherein after the hydrolysis reaction is completed, the reaction temperature is further increased to about 90-95 degrees Celsius to inhibit the enzyme activity. 一種鈣強化豆漿之製備方法,其係將如申請專利範圍第1或2項中任一項所述之大豆胜肽-鈣螯合物添加於豆漿中,其中該鈣強化豆漿之鈣含量介於40~90mg/100ml。 A method for preparing a calcium-enriched soybean milk, which comprises adding the soybean peptide-calcium chelate compound according to any one of claims 1 to 2 to the soybean milk, wherein the calcium content of the calcium-fortified soybean milk is between 40~90mg/100ml. 一種鈣強化豆漿,由申請專利範圍第11項所述之鈣強化豆漿之製備方法製造而得,其中該鈣強化豆漿之鈣含量介於40~90mg/100ml。 A calcium-enhanced soymilk obtained by the method for preparing calcium-fortified soymilk according to claim 11 wherein the calcium-enriched soymilk has a calcium content of 40 to 90 mg/100 ml.
TW100136710A 2011-10-11 2011-10-11 Method for preparing soybean peptide-calcium chelate TWI475962B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW100136710A TWI475962B (en) 2011-10-11 2011-10-11 Method for preparing soybean peptide-calcium chelate
CN201110387656.XA CN103040000B (en) 2011-10-11 2011-11-24 Preparation method of soybean peptide-calcium chelate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW100136710A TWI475962B (en) 2011-10-11 2011-10-11 Method for preparing soybean peptide-calcium chelate

Publications (2)

Publication Number Publication Date
TW201315390A TW201315390A (en) 2013-04-16
TWI475962B true TWI475962B (en) 2015-03-11

Family

ID=48053045

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100136710A TWI475962B (en) 2011-10-11 2011-10-11 Method for preparing soybean peptide-calcium chelate

Country Status (2)

Country Link
CN (1) CN103040000B (en)
TW (1) TWI475962B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104161265A (en) * 2014-07-04 2014-11-26 东北农业大学 Preparation method for low-molecular weight soybean peptide-calcium chelate for enhancing bone density
CN104472852B (en) * 2014-12-11 2017-08-08 齐齐哈尔医学院 It is a kind of calcium fortified rich in lactalbumin polypeptide product and preparation method thereof
CN104920782B (en) * 2015-06-03 2018-04-13 四川大学 A kind of polypeptide chelate calcium preparation and preparation method thereof
CN104905162A (en) * 2015-06-09 2015-09-16 华南理工大学 Method for preparing bean flour and functional soybean protein rich in glyceollin by adopting solid fermentation method
CN106244655A (en) * 2016-08-05 2016-12-21 广州金酮医疗科技有限公司 A kind of protein peptide and calcium chelate thereof and preparation method
CN106983036A (en) * 2017-04-24 2017-07-28 蚌埠农兴达现代农业有限公司 A kind of feed of promotion broiler chicken thymus development
CN106900988A (en) * 2017-04-24 2017-06-30 蚌埠农兴达现代农业有限公司 A kind of egg feedstuff for improving egg quality
CN110720515A (en) * 2019-10-25 2020-01-24 李玉保 Bone collagen polypeptide composite nutrient for improving bone mineral density and preparation method thereof
CN113813362B (en) * 2021-09-27 2023-10-24 山东安为先生物科技有限公司 Stable small peptide chelated calcium, preparation method and application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1273783A (en) * 2000-05-26 2000-11-22 黑龙江省轻工科学研究院 Process for preparing active peptide of soybean protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG106572A1 (en) * 1999-12-02 2004-10-29 Nestle Sa Production of hydrolysate seasoning
CN1683008A (en) * 2005-03-14 2005-10-19 山东轻工业学院 Collagen polypeptide preparation for supplementing calcium and its preparing method
CN101390540A (en) * 2007-09-18 2009-03-25 中国食品发酵工业研究院 High protein, high nutrient soya peptide reinforced old-people milk powder and manufacture method thereof
CN101161114B (en) * 2007-11-02 2010-12-08 中国农业大学 Method of producing soybean peptide-calcium compound

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1273783A (en) * 2000-05-26 2000-11-22 黑龙江省轻工科学研究院 Process for preparing active peptide of soybean protein

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
促進鈣吸收胜肽配料開發,食品工業發展研究所產品及製程中心,94年研發成果,2006/7/1,網址;http://www.ftd.firdi.org.tw/technology-detail.asp?fileid=A-01-00054&item=%A7%DE%B3N%B2%BE%C2%E0%B6%B5%A5%D8 *

Also Published As

Publication number Publication date
CN103040000B (en) 2015-09-09
TW201315390A (en) 2013-04-16
CN103040000A (en) 2013-04-17

Similar Documents

Publication Publication Date Title
TWI475962B (en) Method for preparing soybean peptide-calcium chelate
TWI539902B (en) Lipid metabolism-improving agent
RU2549709C1 (en) Probiotic sour cream production method
JPH09191852A (en) Healthy food
JP4596304B2 (en) Growth hormone secretion promoting composition
KR20060082015A (en) Composition for strengthening bone derived from egg
EP2246060A1 (en) Liver function-protecting agent
CN104814439A (en) Egg white mini-peptide antihypertensive nutrition powder and preparation method thereof
TW201934016A (en) Hydrolysat proteique de fabacees comme source proteique hypoallergenique dans des compositions alimentaires
TWI472298B (en) Peptide product for enhancing calcium absorption and fabrication method thereof
KR20210085755A (en) Food composition for improving athletic performance comprising palatinose syrup and rice protein hydrolysate
JP3979543B2 (en) Antiallergic agent and method for producing the same
CN114431330A (en) Plant nutrient milk shake and preparation method thereof
FI112031B (en) New use of a biologically active product
KR100734944B1 (en) Functional food-composition with calcium lactate and rice bran
CN115843918B (en) Vegetable protein applied to nephrosis patient and preparation method thereof
JP2808281B2 (en) Protein foods and physiological supplements
CN109619570A (en) A kind of infant formula and preparation method thereof of anti-protein allergies
JPH0515339A (en) Protein-like composition, nourishing medicine for serious stress and nourishing medicine for hepatic disease
JPH07228540A (en) Mineral absorbefacient and food comprising the same
JP2005104953A (en) Aqueous alkaline solution for supplementing mineral, method for producing the same and composition for preventing and improving osteoporosis by using the same
JP3605528B2 (en) Weight gain inhibitor
JPH06211690A (en) Ingestion for suppressing lipid in blood
RU2720200C2 (en) Method for preparing an agent for preventing iodine deficiency disorders and immunodeficiency
US20230180778A1 (en) Milk fermentation process